Echo connects often-overlooked infrastructure with globally sourced ideas, talent and capital to build a better, bolder future for the community and the world. A Look Into Oklahoma City's Venture Capital Network and Entrepreneurial Echo Investment Capital's affiliate, Echo Minerals, announces its agreement to sell mineral and royalty interests to Austin, Texas-based Brigham Minerals, Inc. (NYSE: MNRL) for a total value of $32.5 million. The people who make all of this possible, and who will make the Oklahoma City Innovation District a model for the innovation economy. All rights reserved. Public Strategies, Tomas Diaz de la Rubio Oklahoma City has built-in cost advantages for business operation, and when you combine that with an infrastructure that supports the testing and development process, we become a great solution for growing bioscience companies needing access to clinical trial networks and to biomanufacturing, without relying on foreign providers.. All Rights Reserved. The information may be inaccurate, incomplete or outdated. Echo Investment Capital Connect to CRM Summary Investments People Technology Signals & News Similar Companies About Echo is a multi-disciplinary team of strategic investors and operators funding innovation and cutting-edge companies across industries. A key feature of the high-density project is the proposed MAPS 4-funded Innovation Hall. In 2022, Echo Energy and Echo Investment Capital rebranded to Echo. There was an error. The OBIC coalition is supported by more than 40 partners across academia, tribal nations, government, industry, community, investors, and other key stakeholders involved in the continued development of the burgeoning biotechnology cluster in Oklahoma. Researchers, entrepreneurs and big thinkers all converge here in a collaborative environment. Right now. The Glazer family, who have owned United since 2005, now have a decision to make regarding whether they sell their entire 69 per cent shareholding or go down a minority investment route. Echo Investment Capital - Investor in Oklahoma City, Oklahoma - Ask For Earlier, he was Treasurer of Samson Investment . Deka Biosciences has announced the dosing of the first subject in a Phase 1 clinical trial of DK210 (EGFR), a novel cytokine therapy for cancer and inflammatory diseases. Headquartered in Oklahoma City, Echo consists of a team of strategic investors and builders funding innovation in life scie nces, entertainment, real estate, and energy. http://www.adviserinfo.sec.gov/IAPD/Content/Search/iapd_Search.aspx. Get the full list, Youre viewing 5 of 52 co-investors. Smart money for smarter generations. Its a breeding ground where revolutionary ideas can flourish, and Im proud to be a part of it.. President & CEO Echo Investment Capital (Echo Investment Capital) is a Venture Capital Firm located in Oklahoma City, OK United States, North America. The Analyst will be responsible for researching, compiling, and analyzing information on macroeconomic and industry trends and conditions to select and vet Echo's new market niches. Vous pouvez modifier vos choix tout moment en cliquant sur le lien Tableau de bord sur la vie prive prsent sur nos sites et dans nos applications. Headquartered in Oklahoma City, Echo consists of a team of strategic investors and builders funding innovation in energy, media, national security, life sciences, and real estate. Errors are noted below: Thanks for reaching out. The trial aims to evaluate the safety, potential efficacy, and biomarker responses of the therapy in patients with advanced solid cancer(s) expressing epidermal growth factor receptors. No affiliation or endorsement, express or implied, is provided by their use. He has long championed the work of the Economic Development Administration, and this is truly a tribute to his efforts. Wheeler Bio, a CDMO specializing in therapeutic antibodies, has closed its Series A funding round, co-led by Charles River Laboratories and Echo. The Echo Life Sciences Fund I, LLC was launched in 2020 and continues to grow its dedicated team of Oklahoma-based investment professionals. Alloy Therapeutics and Echo Investment Capital Create Wheeler Bio to 2023 www.oklahoman.com. Email:[email protected], 202 W. Boyd St,. Oklahoma City, Oklahoma, United States. The Oklahoma Biotech Innovation Cluster (OBIC) Initiative, a coalition spearheaded by the Greater Oklahoma City Chamber alongside primary coalition partners including the University of Oklahoma, the Oklahoma City Innovation District, and with industry leadership from Echo Investment Capital, has been awarded $35 million through the Build Back SEC.gov Oklahoma City Innovation District | Our Team Si vous ne souhaitez pas que nos partenaires et nousmmes utilisions des cookies et vos donnes personnelles pour ces motifs supplmentaires, cliquez sur Refuser tout. VC Analyst @ Echo Investment Capital in Oklahoma City, OK Its proximity to University of Oklahoma and Oklahoma State University research centers will foster inter-university collaboration, he said. Echo connects often-overlooked infrastructure with globally sourced ideas, talent and capital to build a better, bolder future for the community and the world. We promise to keep your information safe and secure. Founder, CEO Private Equity Learn More Venture Learn More Impact Learn More News April 13, 2023 Wheeler Bio Announces $14M Seed Round To Expand Access To Portable CMC Echo Investment Capital Campus All Rights Reserved. Echo Investment Capital is a multi-disciplinary investment firm with experience managing more than $1.2 billion in capital across industries. BancFirst Corporation, Dr. Quinton Hughes Sr. DK210 (EGFR) is the first of several DiakinesTM developed by Deka, which involves coupling two cytokines onto a single targeting system for enhanced precision and efficacy. Director of Programs & Events Todays announcement is only possible due to the partners working together, and the guidance and support of central Oklahomas congressional delegation. This kind of collaboration falls squarely within our mission at the OU Health Sciences Center, said Interim Senior Vice President and Provost of the Health Sciences Center Dr. Gary Raskob. OKLAHOMA CITY, June 17, 2022 (GLOBE NEWSWIRE) -- Multi-disciplinary investment firm Echo Investment Capital is celebrating the passage of The Oklahoma Research and Development Act, a piece of legislation that creates a grant program designed to attract research and development companies to the state. Oklahoma City developers thrilled to reveal plans for ambitious R&D center Echo Investment Capital (Echo Investment Capital) - Venture Capital They are an exceptional organization, and we are excited to share in their future value creation as new shareholders.. They are part of Info rmation Technology Department and their management level is Non-Manager. Advisory board positions with Boyd Street Venture (A Venture Capital Fund), Larynx (an AI Neural Voice . Win whats next. And it's a great project to locate in the Innovation District, which is projected to generate more than 6,000 jobs over the next three to five years, said Katy Evans Boren, Innovation District CEO. Echo Life Sciences Fund Profile: Investments & Returns | PitchBook "Researchers, engineers, universities and industry leaders are pioneering Oklahoma-born advances in bioscience, aerospace, energy and health. Echo Investment Capital - Overview, News & Competitors | ZoomInfo.com Major scientific advancements are best achieved through strong public-private collaboration, which is exactly what will be accomplished through this coalition, said OU President Joseph Harroz Jr. This exciting initiative unites our regions brightest minds in biotech, and we are grateful that it will leverage OU research expertise to develop life-changing solutions while also fostering economic prosperity for our state., OU Vice President for Research and Partnerships Toms Daz de la Rubia said, we saw this as an opportunity to leverage the strong public and private research assets that exist at the University of Oklahoma, in Oklahoma City, and in the region to create a vibrant ecosystem here that not only fuels our economy but supports increased commercialization and U.S. manufacturing for new drugs and therapies.